SER · Serina Therapeutics, Inc.
$2.07
-0.02 (-0.96%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations within one year of the unaudited condensed consolidated interim financial statements issuance date, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$31.04M
Shares
15.00M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-01-20 | Moreadith Randall | Officer | 91,000 | 2026-01-20 | Stifel Nicolaus & Company Inc |
| 2025-10-14 | Moreadith Randall | Officer | 88,826 | 2025-10-13 | Stifel Nicolaus & Company Inc |
| 2025-06-30 | Moreadith Randall | Officer | 99,674 | 2025-06-30 | Stifel Nicolaus & Company Inc |
Showing 1–3 of 3 filings